Viking Therapeutics, Inc. (VKTX) News Headlines

6/17/2021 7:05:00 AM Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Novel Oral Thyroid Receptor Beta Agonist VK0214 (Press Release)

9/29/2020 6:29:21 AM Pre-market Movers In Healthcare Sector: TNXP, SRNE, GNFT, INO, HUGE…

9/9/2020 7:09:54 AM Viking Therapeutics Says Commences Phase 1 Trial Of VK0214 As Potential Treatment For X-linked Adrenoleukodystrophy

8/28/2020 6:09:17 AM Viking Therapeutics Presents New Data From Phase 2 Study Of VK2809 In Patients With NAFLD And Elevated LDL-Cholesterol

8/20/2020 7:39:54 AM Viking To Present Data From Phase2 Study Of VK2809 In Patients With Non-Alcoholic Fatty Liver Disease&Elevated LDL-C

8/20/2020 7:30:00 AM Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress™ 2020 (Press Release)

7/30/2020 3:08:15 AM ALEC Falls Despite Promising Results, DNLI Makes Progress In COVID-19 Trial, EARS, ONTX On Watch

3/29/2019 7:45:58 AM William Blair Reiterates Viking Therapeutics, Inc. (VKTX) At Outperform

3/14/2019 8:44:35 AM William Blair Reiterates Viking Therapeutics, Inc. (VKTX) At Outperform

10/1/2018 7:51:04 AM William Blair Reiterates Viking Therapeutics, Inc. (VKTX) At Market Perform

8/10/2018 7:55:42 AM William Blair Is Raising Viking Therapeutics, Inc. (VKTX) FY20 Estimate To -0.79 From -0.89

8/10/2018 7:55:29 AM William Blair Is Increasing Viking Therapeutics, Inc. (VKTX) FY19 Estimate To -0.55 From -0.69

8/10/2018 7:55:17 AM William Blair Is Increasing Viking Therapeutics, Inc. (VKTX) FY18 Estimate To -0.44 From -0.51

8/10/2018 7:54:42 AM William Blair Reiterates Viking Therapeutics, Inc. (VKTX) At Outperform

Older Articles